Results 21 to 30 of about 4,196 (141)

Recovery from Myalgic Encephalomyelitis/Chronic Fatigue syndrome developed after severe acute respiratory syndrome coronavirus 2 vaccination: A case report. [PDF]

open access: yesPCN Rep
Abstract Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a neurological adverse effect after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccinations. However, clinicians do not recognize the condition well, and no case report has shown a full recovery.
Kurotori I, Sasao W, Abe M.
europepmc   +2 more sources

Primeiros casos de rejeição em transplante penetrante após vacina contra COVID-19

open access: yesRevista Brasileira de Oftalmologia, 2022
RESUMO Este artigo descreve dois casos de reação imunológica de rejeição de transplante penetrante após a aplicação de dois tipos de vacina contra a COVID-19 – CoronaVac (Sinopharm/Butantan) e MRNA BNT162&2 (Pfizer-BioNTech) – com intervalo de 1 e 10 ...
Tadeu Cvintal, Victor Cvintal
doaj   +1 more source

Side effects of the Pfizer BioNTech vaccine in health workers of a hospital in the southeast of Mexico

open access: yesJournal of Infection in Developing Countries, 2022
Introduction: The goal of this study was to evaluate the side effects of application of the Pfizer BioNTech vaccine on the workers at a Mexican hospital. Methodology: A cross-sectional study was carried out, in which 1351 workers from a tertiary care
Jesús Arturo Ruiz-Quiñones   +5 more
doaj   +1 more source

Prevalence of indeterminate tuberculosis interferon‐gamma release assays in COVID‐19 patients: Systematic review and meta‐analysis

open access: yesHealth Science Reports, Volume 6, Issue 12, December 2023., 2023
Abstract Background and Aims The reliability of interferon‐gamma‐release‐assays (IGRAs) for tuberculosis (TB) testing in coronavirus disease 2019 (COVID‐19) patients is unknown. This study aimed to systematically review the prevalence of indeterminate TB‐IGRA following SARS‐CoV‐2 infection or vaccination and to review associated factors.
Aicha Ben Tekaya   +6 more
wiley   +1 more source

Proteome Organization of COVID-19: Illustrating Targets for Vaccine Development

open access: yesJournal of Pure and Applied Microbiology, 2020
‘COVID-19’ the recent virulent viral infection had influenced the lives of millions globally leading to both loss of life, economic and financial crisis. Coronavirus belongs to family coronaviridae with four genus viz.
Alok Bharadwaj   +3 more
doaj   +1 more source

Sudden Sensorineural Hearing Loss Following Immunization With BNT162b2 or mRNA‐1273: A Danish Population‐Based Cohort Study

open access: yesOtolaryngology–Head and Neck Surgery, Volume 169, Issue 6, Page 1472-1480, December 2023., 2023
Abstract Objective To compare the occurrence of sudden sensorineural hearing loss following immunization with BNT162b2 (Comirnaty®; Pfizer BioNTech) or mRNA‐1273 (Spikevax®; Moderna) to the occurrence among unvaccinated individuals. Study Design Cohort study.
Per Damkier   +6 more
wiley   +1 more source

Assessing the acceptability of COVID‐19 vaccine and its booster dose

open access: yesImmunity, Inflammation and Disease, Volume 11, Issue 9, September 2023., 2023
Abstract Background and Objective Coronavirus disease of 2019 (COVID‐19) vaccinations are essential to control the pandemic and prevent severe COVID‐19 infections. This study aims to assess the acceptability of the COVID‐19 vaccine and the factors that impact the intention to take the COVID‐19 vaccine and its booster dose.
Sawsan Mubarak   +4 more
wiley   +1 more source

Biomaterial‐based gene therapy

open access: yesMedComm, Volume 4, Issue 3, June 2023., 2023
Overview of biomaterial‐based delivery systems for gene therapy. Abstract Gene therapy, a medical approach that involves the correction or replacement of defective and abnormal genes, plays an essential role in the treatment of complex and refractory diseases, such as hereditary diseases, cancer, and rheumatic immune diseases.
Yi Yu   +8 more
wiley   +1 more source

Acquired hemophilia A (AHA) due to anti‐SARS‐CoV‐2 vaccination: A systematic review

open access: yeseJHaem, Volume 4, Issue 2, Page 532-543, May 2023., 2023
Abstract Vaccination against SARS‐CoV2 has been the largest vaccination campaign over the past two decades. The aim of this study is to qualitatively assess the reported cases of acquired hemophilia A (AHA) that developed after COVID‐19 vaccination to further elaborate on incidence, presentation, treatment, and outcomes.We queried Medline (PubMed ...
Fnu Amisha   +3 more
wiley   +1 more source

Various aspects of the relationship between vitiligo and the COVID‐19 pandemic or SARS‐CoV‐2 vaccines: Clinical pearls for dermatologists

open access: yesJournal of Cosmetic Dermatology, Volume 22, Issue 4, Page 1152-1156, April 2023., 2023
Abstract Background Coronavirus disease 2019 (COVID‐19) has given rise to several new onset or exacerbated dermatologic disorders including vitiligo. Aim and Method Here, we present different aspects of relationship between SARS‐CoV‐2 infection or its associated vaccines and vitiligo and aim to provide solutions to overcome the potential challenges ...
Zeinab Aryanian   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy